Opioid Pharmacotherapy for Chronic Non-Cancer Pain in the United States: A Research Guideline for Developing an Evidence-Base
C. Richard Chapman(University of Utah), Constance Weisner(University of California, San Francisco), Martin S. Angst(Stanford Medicine), Lynn R. Webster(Adherent Technologies (United States)), Susan S. Jick(Boston University), Michael R. Von Korff(Kaiser Permanente Washington Health Research Institute), Ernest Volinn(University of Utah), Richard C. Denisco(National Institute on Drug Abuse), Aaron M. Gilson(University of Wisconsin–Madison), Karen M Schoelles(ECRI Institute), Charles E. Inturrisi(Stat Medical Devices (United States)), Roger Chou(Brown University), John D. Loeser(University of Washington), J. David Haddox(Purdue Pharma (United States)), Gary Donaldson(University of Utah), Kathleen M. Foley(Cornell University), Susan D. Horn(Helmholtz Zentrum München), Dennis C. Turk(University of Washington), David L. Lipschitz(University of Utah), Rollin M. Gallagher(University of Pennsylvania), Arthur G. Lipman(Apple (Israel)), Linda Porter(National Institutes of Health), Meredith Noble(ECRI Institute), Michael C. Rowbotham(University of California, San Francisco), Perry G. Fine(University of Utah)
Cited by 172
Related Papers
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
|Psychological Bulletin|2007|3.3k